comparemela.com

Latest Breaking News On - Apeiron group - Page 1 : comparemela.com

Chemomab Therapeutics : Notice and Proxy Statement with respect to the Company s annual general meeting of the shareholders (the Meeting ) to be held on June 10, 2024, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting - Form 6-K

May 3, 2024 Dear Chemomab Therapeutics Ltd. Shareholders: We cordially.

Tel avivNorth carolinaUnited statesHa afonWashington universityRamat ganDuke universityPeter thielSomekh chaikinBalan mosesClaude nicaiseHerzliya pituachNeil cohenChristian angermayerKiryat atidimSigal fattal

Chemomab Therapeutics : Notice and Proxy Statement with respect to the Company s annual general meeting of the shareholders (the Meeting ) to be held on August 7, 2023, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting

July 3, 2023 Dear Chemomab Therapeutics Ltd. Shareholders: We cordially.

Bruxelles capitaleTel avivIsrael generalRamat ganUnited statesSaint luciaCity ofUnited kingdomNissim darvishClaude nicaiseBalan mosesSigal fattalJill quigleyWadi morPeter thielMatthew frankel

StartUPDATES: New developments from healthcare startups

Check out new developments from Alto Neuroscience, Aptus Life, Elion, Lumata Health, and Sound Life Sciences.

Bobby guelichUniversity of washingtonApeiron groupLife sciencesOscar healthLumata healthWolfpack investor networkAlto neuroscienceLightswitch capitalAlkeon capitalSobrato capitalNovartis pharmaValor equity partnersKorify capitalVine venturesWhatif ventures

Alto Neuroscience Raises $35M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Jeff chenChristopher coxBob balohAmit etkinNovartis institutes for biomedical researchApeiron groupAlto neuroscienceLos altosLightswitch capitalAlkeon capitalSobrato capitalNovartis pharmaValor equity partnersKorify capitalVine venturesWhatif ventures

vimarsana © 2020. All Rights Reserved.